Fund Creation
4
2M
3
0.21
0.25
1
- Stages of investment
- Areas of investment
Summary
Fund Creation is the famous VC, which was founded in 2002. The fund was located in Asia if to be more exact in Japan. The main department of described VC is located in the Tokyo.
Among the most popular portfolio startups of the fund, we may highlight REGiMMUNE Corporation. We can highlight the next thriving fund investment areas, such as Biopharma, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the Fund Creation, startups are often financed by NIF SMBC Ventures, Japan Asia Investment, Yasuda Enterprise Development. The meaningful sponsors for the fund in investment in the same round are Yasuda Enterprise Development, New Cycle Capital, NIF SMBC Ventures. In the next rounds fund is usually obtained by Japan Asia Investment, Yasuda Enterprise Development, NIF SMBC Ventures.
The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2008. The usual things for fund are deals in the range of 5 - 10 millions dollars.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.21
- Follow on index
- 0.25
- Investments by industry
- Marketing (2)
- Health Diagnostics (2)
- Biopharma (2)
- Biotechnology (2)
- CRM (1) Show 2 more
- Investments by region
-
- Japan (4)
- Peak activity year
- 2008
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| REGiMMUNE Corporation | 21 Feb 2007 | Biotechnology, Health Diagnostics, Biopharma | Early Stage Venture | 4M | Chiyoda, Japan |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.